Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Letter

5HT2A polymorphism His452Tyr in a German Caucasian systemic sclerosis population

Holger Kirsten1,2,3* email, Jana Burkhardt1* email, Helene Hantmann2 email, Nico Hunzelmann4 email, Peter Vaith5 email, Peter Ahnert1,6 email and Inga Melchers7 email

Institute of Clinical Immunology and Transfusion Medicine, Center for Biotechnology and Biomedicine (BBZ), University of Leipzig, Johannisallee, 04103 Leipzig, Germany

Fraunhofer Institute for Cell Therapy and Immunology, Perlickstr., 04103 Leipzig, Germany

Translational Center for Regenerative Medicine, University of Leipzig, Phillip-Rosenthal-Str., 04103 Leipzig, Germany

Department of Dermatology, University of Cologne, Kerpener Straße, 50924 Cologne, Germany

Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Hugstetter Str., 79106 Freiburg, Germany

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Haertelstr. 16-18, 04107 Leipzig, Germany

Clinical Research Unit for Rheumatology, University Medical Center, Breisacher Str., 79106 Freiburg, Germany

author email corresponding author email* Contributed equally

Arthritis Research & Therapy 2009, 11:403doi:10.1186/ar2606

Published: 26 March 2009


See related research by Beretta et al., http://arthritis-research.com/content/10/5/R103 and related letter by Beretta and Scorza, http://arthritis-research.com/content/11/2/404

First paragraph (this article has no abstract)

Recently, Beretta and colleagues [1] reported a protective association of the serotonin 5-HT2A receptor gene polymorphism His452Tyr (C+1354T, rs6314) with systemic sclerosis (SSc) in an Italian population. 5HT2A accounts for most vasoconstrictive and platelet aggregation due to serotonin activity [2]. Beretta and colleagues also demonstrated that plasma from healthy heterozygous carriers of His452Tyr showed decreased platelet aggregation after serotonin stimulus compared to plasma from healthy individuals homozygous for His452. In consequence, they suggested a functional role of His452Tyr in reducing susceptibility to SSc.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.